Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator Apr 27, 2026 7:00am EDT
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements Mar 18, 2026 6:00am EDT
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 Mar 12, 2026 6:30am EDT
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. Feb 09, 2026 9:53am EST
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab Dec 30, 2025 7:30am EST
